companydata.dkcompanydata.dk

Reumatolog Khurram Ashraf ApS: Financial statements 2022

CVR: 39336081

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

Reumatolog Khurram Ashraf ApS (CVR 39336081) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 594,995 and a net result of DKK 349,297 compared with DKK 403,768 the year before. That is an increase of 13.3% compared with the year before. Equity in the 2022 report amounted to DKK 393,368. The solvency ratio was 38.6%.

Gross Profit
DKK 594,995
Profit/Loss
DKK 349,297
Equity
DKK 393,368
Total Assets
DKK 1,018,459

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-595K349K393K-
2021-525K404K444K-
2020-354K279K319K-
2019-165K128K165K-
2018-48K37K37K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Reumatolog Khurram Ashraf ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Reumatolog Khurram Ashraf ApS: The 2021 annual report is outJul 6, 2022

Reumatolog Khurram Ashraf ApS has published its annual report for 2021. Gross profit came to DKK 525,146, and the net result was DKK 403,768.

About Reumatolog Khurram Ashraf ApS

Reumatolog Khurram Ashraf ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2018. The company is registered under the industry Alment praktiserende lægers aktiviteter. The company was previously named Reumatolog Khurram Ashraf IVS. The management consists of Khurram Ashraf. The company is owned by Speciallægen FZJ Holding ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 633,663 and a net result of DKK 130,666 compared with DKK 46,332 the year before. Equity in the 2025 report amounted to DKK 52,832.

Source: annual report 2025, Danish Business Authority

Other financial years